Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B4061ece6eb5c94f82a1b95452430a062> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B4061ece6eb5c94f82a1b95452430a062 NCIT_P378 "NCI" @default.
- B4061ece6eb5c94f82a1b95452430a062 type Axiom @default.
- B4061ece6eb5c94f82a1b95452430a062 annotatedProperty IAO_0000115 @default.
- B4061ece6eb5c94f82a1b95452430a062 annotatedSource NCIT_C99222 @default.
- B4061ece6eb5c94f82a1b95452430a062 annotatedTarget "An immunoconjugate consisting of a human monoclonal antibody directed against the deletion-mutant of epidermal growth factor receptor, EGFRvIII, conjugated via a non-cleavable linker to the cytotoxic agent maytansinoid DM1, with potential antineoplastic activity. The monoclonal antibody moiety of this immunoconjugate binds to EGFRvIII on tumor cell surfaces. After internalization, the DM1 moiety binds to tubulin, thereby disrupting microtubule assembly/disassembly dynamics and inhibiting cell division and the proliferation of cancer cells that express the EGFRvIII mutant. EGFRvIII, a deletion mutation of exons 2-7 in the epidermal growth factor receptor gene, is overexpressed by a variety of cancers, including glioblastoma multiforme, non-small lung carcinoma, and breast carcinoma." @default.